Will Cyramza with health insurance benefits broaden options for stomach cancer patients?
Will ‘Cyramza(generic name: ramucirumab),’ a secondary treatment for stomach cancer, break the wall of health insurance benefits and become a practical treatment option for stomach cancer patients?
Lilly Korea, on the 2nd, held a press conference to celebrate the Korean health insurance benefits...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.